FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

38030011000001101: Upadacitinib hemihydrate 15mg tablets 28 tablet (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 19-Feb 2020. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1151581000001113 Upadacitinib hemihydrate 15mg tablets 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    1151591000001110 Upadacitinib hemihydrate 15mg tablets 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Upadacitinib hemihydrate 15mg tablets 28 tablet Has VMP Upadacitinib hemihydrate 15mg tablets false Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate 15mg tablets 28 tablet Is a Virtual medicinal product pack false Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate 15mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status false Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate 15mg tablets 28 tablet Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate 15mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Upadacitinib false Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate 15mg tablets 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate 15mg tablets 28 tablet Has specific active ingredient Upadacitinib hemihydrate false Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate 15mg tablets 28 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Is a False Upadacitinib hemihydrate 15mg tablets 28 tablet Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start